Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.
about
Emerging Roles of Strigolactones in Plant Responses to Stress and DevelopmentPlant derived substances with anti-cancer activity: from folklore to practiceThe induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells.Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model.Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair.TES inhibits colorectal cancer progression through activation of p38.Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase.Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells.Strigolactone biology: genes, functional genomics, epigenetics and applications.Prostate Cancer Stem Cells: Viewing Signaling Cascades at a Finer Resolution.Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation.Recent advances in the synthesis of analogues of phytohormones strigolactones with ring-closing metathesis as a key step.Plant-derived compounds strigolactone GR24 and pinosylvin activate SIRT1 and enhance glucose uptake in rat skeletal muscle cells.Parasitic weed management by using strigolactone-degrading fungi.Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells.Strigolactones-a novel class of phytohormones as anti-cancer agents
P2860
Q26752498-5552DA90-F21D-44F7-9FFE-21ADD4A668BBQ26781498-FEDE5111-23C7-4900-B9EA-E9B90E88852BQ34786538-153C705A-90F1-476C-8850-4056C57802F7Q36053940-2B3AD18A-A663-4226-8211-2F59DA514E0AQ36838962-03582E7B-1D6A-4778-8250-CB1F1F10EB2AQ37046504-54C876D9-75C7-46C7-80CD-E58CA35B2F87Q37564565-1D406CAF-B8FD-4189-8D94-667FAC6E7D83Q37708991-38D1818A-6127-4AA2-8902-9F88A5A6C9BFQ38369468-235E85B2-9EEA-4C4A-BE64-411A6F829BFCQ38634918-A87FC883-CB7E-4C55-B034-CFDB2C7AA687Q38669759-536418AC-6281-4793-B6EE-7D21DBB598B6Q38723375-1385CC6D-7566-4FD1-8687-CD9CC6DD4CEBQ39068497-70926EC4-5445-4FDE-80FA-5A1458FB2D5EQ46225087-774CBD8E-5F84-49C7-AA4F-B7A13FB3BE02Q47335697-2A013673-A15E-498E-8F65-2CFC3513CEBBQ48022945-0F7E9826-B892-4E0A-99EB-15391D609D17Q48046295-73A66E0D-6738-4247-A336-E9177B140B56Q48264236-DC11C26E-D748-4FB4-BC2D-8AC57AFF6BA0Q49245661-06ADBED4-A6D4-419B-923C-F1C23866242BQ58564988-9393E066-928F-49E2-BCE4-ED8732438577
P2860
Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Strigolactone analogues induce ...... primary prostate cancer cells.
@en
type
label
Strigolactone analogues induce ...... primary prostate cancer cells.
@en
prefLabel
Strigolactone analogues induce ...... primary prostate cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Strigolactone analogues induce ...... primary prostate cancer cells.
@en
P2093
Adam S Feldman
Christopher Albanese
Claire B Pollock
Cristina Prandi
Hinanit Koltai
Hyojung Lee
Lymor Ringer
Olga C Rodriguez
Richard J Lee
Richard Schlegel
P2860
P304
P356
10.18632/ONCOTARGET.1849
P407
P577
2014-03-01T00:00:00Z